𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The making of the dominant MHC class I ligand SYFPEITHI

✍ Scribed by Tobias P. Dick; Stefan Stevanović; Wieland Keilholz; Thomas Ruppert; Ulrich Koszinowski; Hansjörg Schild; Hans-Georg Rammensee

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
135 KB
Volume
28
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of photodynamic therapy on tu
The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules
✍ Alan Belicha-Villanueva; Jonah Riddell; Naveen Bangia; Sandra O. Gollnick 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

## Abstract ## Background and Objective Photodynamic therapy (PDT) is FDA‐approved anti‐cancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumor‐specific immune response that is dependent on cytotoxic T lymphocytes

The peptide-binding strategy of the MHC
The peptide-binding strategy of the MHC class II I-A molecules
✍ Boris Reizis; Miriam Eisenstein; Felix Mor; Irun R Cohen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 403 KB

he allele-specific peptidebinding motifs of major histocompatibility complex (MHC) proteins, originally discovered by pool sequencing of MHC class I-bound peptides 1 , provide a biochemical basis for the phenomenon of MHC restriction of T-cell responses. However, the analysis of class II peptide mot